Phase-II trials for new clot buster drug approved

Bio-therapeutic drug, Clot Specific Streptokinase, meant for patients who suffer heat attack, was developed using bacteria

IMTech Chandigarh to start novel coronavirus genome sequencing

Two other institutes under CSIR already on the job